Company: SMNR
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001193125-25-277536
Chunk: 9

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-11-12
Form: 10-Q
Item: Item 6
Chunk 9
---
ExhibitNumber	 
     Description	 
     Form	 
     File/Reg. No.	 
     Exhibit 
     Filing Date	 

     2.1#
     Agreement and Plan of Merger, dated as of August 30, 2024, by and among Denali Capital Acquisition Corp., Denali Merger Sub Inc. and Semnur Pharmaceuticals, Inc.
     S-4
     333-283019
     Annex A-1
     August 12, 2025

     2.2
     Amendment No. 1 to Agreement and Plan of Merger, dated as of April 16, 2025, by and among Denali Capital Acquisition Corp., Denali Merger Sub Inc. and Semnur Pharmaceuticals, Inc.
     S-4
     333-283019
     Annex A-2
     April 21, 2025

     2.3
     Amendment No. 2 to Agreement and Plan of Merger, dated as of July 22, 2025, by and among Denali Capital Acquisition Corp., Denali Merger Sub Inc. and Semnur Pharmaceuticals, Inc.
     S-4
     333-283019
     Annex A-3
     July 23, 2025

     3.1
     Restated Certificate of Incorporation of Semnur Pharmaceuticals, Inc.
     8-K
     001-41351
     3.1
     September 26, 2025

     3.2
     Certificate of Designations of Semnur Pharmaceuticals, Inc.
     8-K
     001-41351
     3.2
     September 26, 2025

     3.3
     Bylaws of Semnur Pharmaceuticals, Inc. 
     8-K
     001-41351
     3.3
     September 26, 2025

     10.1
     Amendment to Advisory Services Agreement, dated as of July 22, 2025, by and between Wise Orient Investments Limited and Semnur Pharmaceuticals, Inc.
     S-4
     333-283019 
     10.23.1
     July 23, 2025

     10.2
     Amendment to Advisory Services Agreement, dated as of July 22, 2025, by and between 450W42ND MIMA, LLC and Sem